J9183 Gemcitabine intravesical system, 225 mg
Billable / valid for submission HCPCS Release 2026Q3
Short description: Gemcitabine intravesical sys
Version history
| Release | Valid from | Valid to | Description | Billable |
|---|---|---|---|---|
| 2026Q3 | 2026-07-01 | current | Gemcitabine intravesical system, 225 mg | yes |
Related codes in J91
- J9100 Injection, cytarabine, 100 mg
- J9118 Injection, calaspargase pegol-mknl, 10 units
- J9119 Injection, cemiplimab-rwlc, 1 mg
- J9120 Injection, dactinomycin, 0.5 mg
- J9130 Dacarbazine, 100 mg
- J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj
- J9145 Injection, daratumumab, 10 mg
- J9150 Injection, daunorubicin, 10 mg
- J9153 Injection, liposomal, 1 mg daunorubicin and 2.27 mg cytarabine
- J9155 Injection, degarelix, 1 mg
- J9161 Injection, denileukin diftitox-cxdl, 1 mcg
- J9171 Injection, docetaxel, 1 mg
- J9172 Injection, docetaxel (docivyx), 1 mg
- J9173 Injection, durvalumab, 10 mg
- J9174 Injection, docetaxel (beizray), 1 mg
- J9175 Injection, elliotts' b solution, 1 ml
- J9176 Injection, elotuzumab, 1 mg
- J9177 Injection, enfortumab vedotin-ejfv, 0.25 mg
- J9178 Injection, epirubicin hcl, 2 mg
- J9179 Injection, eribulin mesylate, 0.1 mg